(Date:11/5/2009)...OK, N.Y., Nov. 5 BioSpec...armaceutical company developing first-in-class col...cial results for the third quarter ended September...n September of this year, the FDA,s Arthritis Advi...of 12-0, the approval of XIAFLEX(TM) for the treat...
(Date:11/5/2009)...EGO, CA, November 5, 2009 /PRNewswire-FirstCall/ -...d on using proprietary taste receptor-based techno...e food, beverage, and ingredient supply industries...inancial results for the third quarter ended Septe... third quarter of 2009, compared to $4.0 million f...
(Date:11/5/2009)...YMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-First... ("BMP Sunstone" or the "Company") today announced...009 financial results on,Monday, November 9, 2009,...ill hold a conference call at 5:00 pm ET on Novemb... Listeners may access the call by,dialing 1-888-71...
(Date:11/5/2009)... Brooke Sanders brings a new look to ...RWEB) November 5, 2009 -- Professional Reprographi...phics company is pleased to present Brooke Sanders... graphics/PR specialist. The addition of Brooke to...rowth within Professional Reprographics., , ,Brook...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2...stCall/ - Oncolytics Biotech Inc.,("Oncolytics") (...successfully transferred cGMP production for REOLY...M), a Division of Sigma-Aldrich Corporation.,This ...40 litres announced,by the Company last year., Yi...nt doses to support,future development plans leadi...
...arient, Inc.,(Nasdaq: CLRT ), a premier anatomic ...for pathologists, oncologists and the pharmaceutic...resident and Chief Financial Officer,Jim Agnello, ...expected to,continue to serve as Chief Financial O...ain with the company as an employee or consultant ...
... 22 Amsterdam,Molecular Therapeutics (Euronext: A...today announced that it obtained a license from La...nced small nuclear RNA,(snRNA)-based exon-skipping... dystrophy (DMD). The combination with AMT,s propr...latform potentially makes up a,long-term treatment...
Other Biology Technology:Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) 2Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) 3Jim Agnello to Resign as Clarient Chief Financial Officer 2Jim Agnello to Resign as Clarient Chief Financial Officer 3Jim Agnello to Resign as Clarient Chief Financial Officer 4AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy 2AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy 3(Date:11/6/2009)...ion is now open for the Society of Interventional ...(IO) Therapies" Webinar, which will provide the la...atment of liver tumors, kidney tumor ablation and ...n of physicians, scientists and allied health prof...ough pioneering advances in image-guided therapy. ...
(Date:11/6/2009)...r 06, 2009) The Monell Center and the Chinese Aca... International Meeting on Taste and Smell Research...S, the meeting will be the first international mee...lan Leshner, Chief Executive Officer, American Ass...ive Publisher of Science magazine, will open the m...
(Date:11/4/2009)...h scientists are reluctant to officially endorse g...ontinues to grow about its protective effects, inc... Prevention Research , a journal of the American A...e reduction in oral cancer. , Vassiliki Papadim...partment of Thoracic/Head and Neck Medical Oncolog...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2HIPAA com Launches HIPAA TV 57226 1HIPAA com Launches HIPAA TV 57226 2Disability Matters 3A Learn Your Rights Preserve Your Independence 57224 1Disability Matters 3A Learn Your Rights Preserve Your Independence 57224 2Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 57222 1Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 57222 2Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 57222 3Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 57222 4Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 57222 5Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 57222 6Sperm viability Fluorometric (green) Assay Kit, LIVE/DEAD® from Molecular Probes (Invitrogen)
N-terminal Sequencing from Primm Biotech, Inc.
SlowFade Antifade Kit with DAPI from Molecular Probes (Invitrogen)
Japanese medaka Vitellogenin Standard from Cayman Chemical
Biology Products: